Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Biochimica Et Biophysica Acta|December 14, 1976
The lipid composition of plasma membrane subfractions originating from the three major functional domains of the rat hepatocyte cell surfaceT Kremmer, M H Wisher, W H EvansPathology Oncology Research : POR|September 22, 1999
Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progressionT Bánfalvi, K Gilde, M Boldizsár, et al.Experimental Cell Biology|January 1, 1984
Polyamine metabolism in P388 leukemia cells and in ascites tumor-bearing miceT Kremmer, L Selmeci, S Bardócz, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 16, 1991
A re-evaluation of the lipid-bound sialic acid determinationZ Végh, T Kremmer, M Boldizsár, et al.Orvosi Hetilap|October 14, 1998
[Serum acid alpha-1-glycoprotein (APG) levels in gastrointestinal tumors]A Szilvás, G Székely, T Kremmer, et al.FEBS Letters|February 21, 1983
Cyclic AMP-dependent protein kinase stimulates the formation of polyphosphoinositides in lymphocyte plasma membraneB Sarkadi, A Enyedi, A Faragó, et al.Toxicology and Applied Pharmacology|September 30, 1984
Effects of bacterial endotoxins and their detoxified derivatives on serum and liver lipids in miceD Gaál, T Kremmer, Z Bálint, et al.European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanomaT Bánfalvi, K Gilde, M Gergye, et al.Thrombosis Research|May 1, 1982
Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'P J Sørensen, G Sas, I Petó, et al.Anti-Cancer Drugs|April 9, 1999
Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell linesI Pályi, T Kremmer, A Kálnay, et al.Pageof 3